A single intravenous dose generated cancer-killing immune cells without cell harvesting, manufacturing, or chemotherapy.
I'd really like to know why they stopped the trial early, and the fact that they didn't disclose that makes me want to know even more.
This would be transformational in our field. This would, in theory, make CAR-T available to community sites.
I'd really like to know why they stopped the trial early, and the fact that they didn't disclose that makes me want to know even more.
This would be transformational in our field. This would, in theory, make CAR-T available to community sites.